Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
This intro covers reliable checks and habits to ensure personal budgeting stays accurate and aligned with your financial goals.
14,583 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
A top Wells Fargo strategist urges retail investors to look for buying opportunities on market dips sparked by Fed ti...
Berkshire Hathaway's Greg Abel recently bought Macy's stock, sparking questions about value and strategy. This in-dep...
Oklo is combining AI with nuclear reactor design to shorten development timelines and improve safety. This article br...
OpenAI just signaled might delay its IPO, sending ripples through AI investors and chipmakers. This guide breaks down...
The data center build-out accelerating wave is reshaping where investors place bets. Beyond chips, three infrastructu...
Memory prices and AI data demands have put Micron and Sandisk in the spotlight. This piece breaks down what’s driving...
Sezzle continues to gain traction in a competitive BNPL market. This article examines why sezzle still looks attracti...
As markets shift and longevity rises, a financial advisor says you’re likely undervaluing the need for flexible incom...
Two AI giants, Microsoft and Nvidia, offer very different routes to growth. This guide breaks down why one might fit ...
As AI workloads expand, data center power stocks are seeing a fresh wave of orders and upgraded guidance. This report...
C.H. Robinson is pursuing a Lean AI powered transformation led by CEO Dave Bozeman, aiming to turn the freight broker...